Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.

Karl D Lewis; William A Robinson; Martin McCarter; Nathan Pearlman; Steven J O'Day; Clay Anderson; Thomas T Amatruda; Anna Baron; Chan Zeng; Maude Becker

doi:10.1200/JCO.2005.04.5344

Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.

Identifier:nobleid.org/w1/20260515/DFBA8C0D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFBA8C0D.svg?ark=w1%2F20260515%2FDFBA8C0D)](https://nobleid.org/work/w1/20260515/DFBA8C0D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.

Identifier:nobleid.org/w1/20260515/DFBA8C0D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DFBA8C0D.svg?ark=w1%2F20260515%2FDFBA8C0D)](https://nobleid.org/work/w1/20260515/DFBA8C0D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work